Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App

NCT06643286 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06643286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06643286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
December 1, 2026
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin), melanoma stage, melanoma, stage ii, stage i, survivorship